Search research articles
Contact Us
Filters
Showing results (51-60 of 434) with videos related to
Page
of 44
Sort By:
Expert Review of Anticancer Therapy
|
November 21, 2007
Cancer stem cells and brain tumors: uprooting the bad seeds
Da Yong Lee, David H Gutmann
The Lancet. Neurology
|
July 18, 2014
Neurofibromatosis type 1: a multidisciplinary approach to care
Angela C Hirbe, David H Gutmann
Neuro-Oncology
|
May 22, 2019
Genetic and genomic alterations differentially dictate low-grade glioma growth through cancer stem cell-specific chemokine recruitment of T cells and microglia
Xiaofan Guo, Yuan Pan, David H Gutmann
Oncoimmunology
|
August 3, 2025
Pan-cancer single cell transcriptomic clustering reveals heterogeneous CD8<sup>+</sup> exhausted T cell populations with different immune checkpoint inhibitor responses
Rui Mu, Rasha Barakat, David H Gutmann
Genes & Development
|
August 3, 2017
The power of the few
Ran Chen, Yuan Pan, David H Gutmann
Developmental Cell
|
January 24, 2023
Neurons as stromal drivers of nervous system cancer formation and progression
Corina Anastasaki, Yunqing Gao, David H Gutmann
Frontiers in Genetics
|
March 19, 2019
Commentary: Identification of Mutation Regions on <i>NF1</i> Responsible for High- and Low-Risk Development of Optic Pathway Glioma in Neurofibromatosis Type I
Corina Anastasaki, Feng Gao, David H Gutmann
Nature Neuroscience
|
December 30, 2015
The role of microglia and macrophages in glioma maintenance and progression
Dolores Hambardzumyan, David H Gutmann, Helmut Kettenmann
Oncotarget
|
May 27, 2017
KIR2DL5 mutation and loss underlies sporadic dermal neurofibroma pathogenesis and growth
Corina Anastasaki, Sonika Dahiya, David H Gutmann
Disease Models & Mechanisms
|
February 21, 2022
RAS and beyond: the many faces of the neurofibromatosis type 1 protein
Corina Anastasaki, Paola Orozco, David H Gutmann
Page
of 44
Search research articles
Search
Showing results (51-60 of 434) with videos related to
Sort By:
Page
of 44
Expert Review of Anticancer Therapy
|
November 21, 2007
Cancer stem cells and brain tumors: uprooting the bad seeds
Da Yong Lee, David H Gutmann
The Lancet. Neurology
|
July 18, 2014
Neurofibromatosis type 1: a multidisciplinary approach to care
Angela C Hirbe, David H Gutmann
Neuro-Oncology
|
May 22, 2019
Genetic and genomic alterations differentially dictate low-grade glioma growth through cancer stem cell-specific chemokine recruitment of T cells and microglia
Xiaofan Guo, Yuan Pan, David H Gutmann
Oncoimmunology
|
August 3, 2025
Pan-cancer single cell transcriptomic clustering reveals heterogeneous CD8<sup>+</sup> exhausted T cell populations with different immune checkpoint inhibitor responses
Rui Mu, Rasha Barakat, David H Gutmann
Genes & Development
|
August 3, 2017
The power of the few
Ran Chen, Yuan Pan, David H Gutmann
Developmental Cell
|
January 24, 2023
Neurons as stromal drivers of nervous system cancer formation and progression
Corina Anastasaki, Yunqing Gao, David H Gutmann
Frontiers in Genetics
|
March 19, 2019
Commentary: Identification of Mutation Regions on <i>NF1</i> Responsible for High- and Low-Risk Development of Optic Pathway Glioma in Neurofibromatosis Type I
Corina Anastasaki, Feng Gao, David H Gutmann
Nature Neuroscience
|
December 30, 2015
The role of microglia and macrophages in glioma maintenance and progression
Dolores Hambardzumyan, David H Gutmann, Helmut Kettenmann
Oncotarget
|
May 27, 2017
KIR2DL5 mutation and loss underlies sporadic dermal neurofibroma pathogenesis and growth
Corina Anastasaki, Sonika Dahiya, David H Gutmann
Disease Models & Mechanisms
|
February 21, 2022
RAS and beyond: the many faces of the neurofibromatosis type 1 protein
Corina Anastasaki, Paola Orozco, David H Gutmann
Page
of 44